The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Endometrial, or uterine, cancer affects more than 60,000 women in the U.S. each year. It is one of the few cancers in which incidence is increasing. Survival for early-stage endometrial cancer ...

Cancer incidence rates among women under 50 are increasing, with breast and thyroid cancer accounting for almost half of all ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Individuals in food deserts are more likely to be diagnosed with advanced-stage cervical and uterine cancers. Food insecurity correlates with higher mortality rates for cervical, uterine, and ovarian ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...